General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents

Tender description

NHS England seeks to appoint a suitably qualified and experienced supplier with the capability to supply an existing antimicrobial to the NHS in England via a subscription-based payment model. This procurement will be conducted by NHS England. The contract entered into pursuant to this procurement will be between the successful supplier and NHS England (the National Health Service Commissioning Board). Organisations wishing to participate in the procurement must have at least one EU licensed antimicrobial that has a UK launch dated on or between 1 January 2017 and 31 December 2019 and that is active against one or more pathogens on the World Health Organisation priority pathogen list. There is no limit on the number of antimicrobials that an organisation can offer. Contracts awarded pursuant to the procurement are for use by the Department of Health and Social Care, Public Health England, the NHS in England, and by private sector healthcare contractors and agents working on behalf of the aforementioned. The successful supplier will be responsible for supply of the selected antimicrobial from 1 April 2022. The duration of any contract awarded will be for an initial period of three (3) years, with the option to extend (by mutual agreement) for an additional period or periods up to seven (7) years. Further information is set out in the procurement documents which are available to download (see below for details). NHS England intends to use the Bravo Solution eTender portal in this procurement. To register and express interest — log on to the portal at: https://nhsengland.bravosolution.co.uk (registration and use of the website is free of charge).